Nephros, Inc.
NEPH
$3.42
-$0.13-3.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 801.00K | 74.00K | -929.00K | -1.29M | -1.44M |
| Total Depreciation and Amortization | 143.00K | 137.00K | 153.00K | 176.00K | 194.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 847.00K | 851.00K | 1.22M | 1.28M | 1.39M |
| Change in Net Operating Assets | -1.29M | -1.55M | -2.48M | -1.01M | -266.00K |
| Cash from Operations | 502.00K | -492.00K | -2.03M | -848.00K | -121.00K |
| Capital Expenditure | -55.00K | -55.00K | -130.00K | -130.00K | -75.00K |
| Sale of Property, Plant, and Equipment | 5.00K | 5.00K | 5.00K | 5.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -50.00K | -50.00K | -125.00K | -125.00K | -75.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.00K | -5.00K | -7.00K | -7.00K | -7.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.00K | -5.00K | -7.00K | -7.00K | -7.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 448.00K | -547.00K | -2.17M | -980.00K | -203.00K |